Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Cerilliant
Express Scripts
Daiichi Sankyo
Fish and Richardson
US Army
Chubb
Julphar
Deloitte
Fuji

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075393

« Back to Dashboard

NDA 075393 describes HALOPERIDOL DECANOATE, which is a drug marketed by Fresenius Kabi Usa, Gland Pharma Ltd, Hospira, Mylan Labs Ltd, Sandoz Inc, Teva Pharms Usa, and West-ward Pharms Int, and is included in eight NDAs. It is available from seven suppliers. Additional details are available on the HALOPERIDOL DECANOATE profile page.

The generic ingredient in HALOPERIDOL DECANOATE is haloperidol decanoate. There are twenty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the haloperidol decanoate profile page.
Summary for 075393
Tradename:HALOPERIDOL DECANOATE
Applicant:Teva Pharms Usa
Ingredient:haloperidol decanoate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 075393
Suppliers and Packaging for NDA: 075393
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075393 ANDA Teva Parenteral Medicines, Inc. 0703-7011 0703-7011-03 10 VIAL, SINGLE-DOSE in 1 CARTON (0703-7011-03) > 1 mL in 1 VIAL, SINGLE-DOSE (0703-7011-01)
HALOPERIDOL DECANOATE haloperidol decanoate INJECTABLE;INJECTION 075393 ANDA Teva Parenteral Medicines, Inc. 0703-7013 0703-7013-01 1 VIAL, MULTI-DOSE in 1 CARTON (0703-7013-01) > 5 mL in 1 VIAL, MULTI-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 50MG BASE/ML
Approval Date:May 11, 1999TE:AORLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 100MG BASE/ML
Approval Date:May 11, 1999TE:AORLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Novartis
Fuji
Chinese Patent Office
Express Scripts
QuintilesIMS
Chubb
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot